Ernexa Therapeutics ERNA
NASDAQ ERNA
$2.96 -0.24 (-7.50%)
At close: Oct 1, 2026 · 4:00 PM EDT

Ernexa Therapeutics (ERNA) Share-based Compensation (2010 - 2026)

Updated

Ernexa Therapeutics' Share-based Compensation was $320,000 in Q2 2026, down 13.0% from $368,000 a year earlier but up 3.6% from the prior quarter.

Analysis

Ernexa Therapeutics (ERNA) Share-based Compensation (2010 - 2026) Analysis & Trends

On a trailing twelve-month basis, Ernexa Therapeutics' Share-based Compensation was $1.26 million through Jun 30, 2026, down 25.5% year-over-year; for FY2025, it was $1.5 million, down 1.6% from FY2024.

  • Share-based Compensation shows a five-year compound annual growth rate of 75.1% (FY2020 to FY2025).
  • In earlier years, Share-based Compensation was $1.52 million in FY2024 (+22.4%), $1.24 million in FY2023 (-57.7%), $2.94 million in FY2022 (-43.9%) and $5.24 million in FY2021.
  • Quarterly Share-based Compensation has moved between $165,000 (Q4 2023) and $1.93 million (Q4 2021) over five years.
  • Compared with a year earlier, Share-based Compensation has declined for five straight quarters, with growth averaging 31.0% over the last eight quarters.
  • The best year-over-year quarter for Share-based Compensation over five years was Q1 2022 (growth of 182.3%); the worst was Q4 2022 (a decline of 79.5%).
  • Per Business Quant data, ERNA's Share-based Compensation in the three quarters before Q2 2026 was $309,000 (Q1 2026), $333,000 (Q4 2025) and $293,000 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Stock Comp. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 458.00 Mn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 166.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 298.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 165.00 Mn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 231.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 249.00 Mn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 170.20 Mn
10 Ernexa Therapeutics 3.74 Mn 3.74 Mn - 320,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 320,000.00
Mar 31, 2026 309,000.00
Dec 31, 2025 333,000.00
Sep 30, 2025 293,000.00
Jun 30, 2025 368,000.00
Mar 31, 2025 502,000.00
Dec 31, 2024 410,000.00
Sep 30, 2024 405,000.00
Jun 30, 2024 423,000.00
Mar 31, 2024 282,000.00
Dec 31, 2023 165,000.00
Sep 30, 2023 174,000.00
Jun 30, 2023 214,000.00
Mar 31, 2023 689,000.00
Dec 31, 2022 397,000.00
Sep 30, 2022 476,000.00
Jun 30, 2022 879,000.00
Mar 31, 2022 1.18 Mn
Dec 31, 2021 1.93 Mn
Sep 30, 2021 1.73 Mn
API Access

Ernexa Therapeutics Share-based Compensation API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=share-based-compensation&ticker=ERNA&period=max&api_key=YOUR_API_KEY